LAURUSLABS
Laurus Labs Limited
Healthcare
Share price
₹2,295
Market cap
₹1.2L Cr
1Y return
▲ 133%
A research-driven pharmaceutical and biotechnology company specializing in Active Pharmaceutical Ingredients for anti-retroviral, oncology, cardiovascular, and gastroenterology therapies with global leadership positions in select segments. Laurus Labs operates multiple facilities approved by major regulatory agencies including USFDA, WHO-Geneva, EMA, and others. The company provides integrated contract manufacturing and development services to international pharmaceutical innovators across clinical development through commercial production stages.
Investors holding Laurus Labs Limited
1.32%
1.07%
Recent moves 7
1newest move
Members onlyIncluding 1 exit
Unlock this moveSBI Life InsuranceNew position
SBI Life Insurance now holds a 1.07% stake in Laurus Labs Limited, up from under 1% in the previous quarter, with a holding of 57,90,000 shares.
Read more
American Funds (Capital Group)Decreased
American Funds (Capital Group) cut its stake in Laurus Labs from 7.05% to 5.79%, selling 67,80,688 shares.
Read more
Mirae Asset Mutual FundDecreased
Mirae Asset Mutual Fund decreased its stake in Laurus Labs from 4.33% to 4.02%, selling 16,86,780 shares.
Read more
Kotak OffshoreDecreased
Kotak Offshore decreased its stake in Laurus Labs, selling 297,109 shares and reducing its holding from 1.06% to 1.01%.
Read more
American Funds (Capital Group)Decreased
American Funds (Capital Group) decreased its stake in Laurus Labs from 8.15% to 7.05%, selling 5,988,473 shares.
Read more
Mirae Asset Mutual FundDecreased
Mirae Asset Mutual Fund decreased its stake in Laurus Labs Limited from 4.47% to 4.33% by reducing its shareholding from 24,110,341 to 23,387,661 shares.
Read more
Track the whales in Laurus Labs Limited
Get alerted the moment a top investor buys or sells.
Start 7 days for ₹1